A Dual GIP/GLP-1 Receptor Co-Agonist for the Treatment of Type 2 Diabetes With Unmatched Effectiveness Regrading Glycaemic Control and Body Weight Reduction
They: Increase insulin release when blood sugar rises Decrease glucagon, which helps prevent blood sugar spikes Slow gastric emptying, so food moves more gradually through the digestive tract Increase feelings of fullness and reduce appetite Signal in the brain to influence hunger, cravings, and reward Together, these effects change how your body processes food, regulates energy, and responds to hunger signals
RCT and case series studies of moderate-quality indicated that L-carnitine did not influence serum lipid profiles except for reducing ApoB
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)
We separated nuclear and cytoplasmic proteins and calculated the ratio of p-P53 to total P53 in each fraction